Suchergebnisse - (Standardsuche:"novel coronavirus" OR Covid OR "Sars-CoV" OR "CoV-2" OR ncov)

PubPharm (352)

1

Strong cross immune responses against sarbecoviruses but not merbecoviruses in SARS-CoV-2 BA.5/BF.7-infected individuals with or without inactivated COVID-19 vaccination

enthalten in: The Journal of infection | 2024

von Sun, L. | Man, Q. | Zhang, H. | +5

2

Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized with COVID-19 (DisCoVeRy) : A phase 3, randomized, double-blind, placebo-controlled trial

enthalten in: The Journal of infection | 2024

von Hites, M. | Lapique, E. | Massonnaud, C. | +84

3

Booster doses of COVID-19 vaccine enhance neutralization efficiency against XBB.1.5

enthalten in: The Journal of allergy and clinical immunology | 2024

von Sakr, E. | Almeida, N. | Langlois, M. | +2

4

SARS-CoV-2 breakthrough infections following inactivated vaccine vaccination induce few neutralizing antibodies against the currently emerging Omicron XBB variants

enthalten in: Virologica Sinica | 2024

von Shen, F. | Liang, C. | Yang, C. | +8

5

Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent vaccine in infection-naive and XBB-infected individuals

enthalten in: The Lancet. Infectious diseases | 2024

von Kosugi, Y. | Kaku, Y. | Hinay, A. | +10

6

Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure

enthalten in: The Lancet. Infectious diseases | 2024

von Yang, S. | Yu, Y. | Xu, Y. | +14

ErratumIn: Lancet Infect Dis. 2024 Jan 3;:. - PMID 38184002

7

SARS-CoV-2 neutralising antibody response to bivalent booster after omicron infection

enthalten in: The Lancet. Microbe | 2024

von Springer, D. | Medits, I. | Weseslindtner, L. | +2

8

A booster of Delta-Omicron RBD-dimer protein subunit vaccine augments sera neutralization of Omicron sub-variants BA.1/BA.2/BA.2.12.1/BA.4/BA.5

enthalten in: Emerging microbes & infections | 2023

von Duan, M. | Duan, H. | An, Y. | +7

9

An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults

enthalten in: Emerging microbes & infections | 2023

von Li, T. | Luo, D. | Ning, N. | +8

10

Heterologous Omicron-adapted vaccine as a secondary booster promotes neutralizing antibodies against Omicron and its sub-lineages in mice

enthalten in: Emerging microbes & infections | 2023

von Liu, J. | He, Q. | Gao, F. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[36]